<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000662508">
  <TermName>FOLFIRI-bevacizumab regimen</TermName>
  <TermPronunciation>(…. beh-vuh-SIH-zoo-mab REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A chemotherapy combination used as an initial treatment of colorectal cancer that has spread. It includes the drugs leucovorin (folinic acid), fluorouracil, irinotecan hydrochloride, and bevacizumab. Also called FOLFIRI-Avastin regimen and FOLFIRI-bevacizumab.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000725967" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;FOLFIRI-bevacizumab regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000725966" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen FOLFIRI y bevacizumab&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen FOLFIRI y bevacizumab</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento inicial del cáncer colorrectal que se ha diseminado. Incluye los medicamentos leucovorina (ácido folínico), fluorouracilo, clorhidrato de irinotecán y bevacizumab. También se llama FOLFIRI y bevacizumab y régimen FOLFIRI y Avastin.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2010-04-26</DateFirstPublished>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000698393" url="/about-cancer/treatment/drugs/FOLFIRI-BEVACIZUMAB">FOLFIRI-BEVACIZUMAB</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
